December 21 Practice & Trends On the Cover Getting naloxone in the hands of those who need it most PT December 2022 Harm reduction experts know that naloxone isn't the single solution to the opioid overdose crisis. Loren Bonner
December 21 Practice & Trends AFIB Pharmacists have future role in atrial fibrillation management PT December 2022 Pharmacists are a potentially untapped resource for atrial fibrillation (AFib) management, according to a new research paper in the American Journal of Medicine. Loren Bonner
December 21 Practice & Trends Vaccine Errors ISMP identifies non-COVID-19-related vaccine errors PT December 2022 In a recent report published by the Institute of Safe Medical Practices (ISMP), more than 1,400 vaccine-related errors were reported and analyzed within the ISMP National Vaccine Errors Reporting Program (ISMP VERP) during a 19-month period from June 2020 to December 2021. Ariel L. Clark, PharmD
December 21 Practice & Trends Flu Shots Top 5 questions about this year's flu vaccination PT December 2022 CDC estimates that the United States will experience a high influenza disease burden for the 2022–2023 season. Brooke Whittington, PharmD
December 21 Practice & Trends On the Docket Court holds that pharmaceutical product placement may be a representation of product quality PT December 2022 Most states have consumer protection laws that authorize lawsuits against retailers who represent their products as having characteristics that the products actually do not have. David B. Brushwood, BSPharm, JD
December 21 Today's Perspective Today's Perspective Pharmacists can help provide access to much-needed naloxone PT December 2022 According to CDC, nearly 50,000 people died from an opioid-involved overdose in 2019, and this number jumped to about 100,000 deaths in 2020.
December 21 Association Perspective Association Perspective A year of positive steps forward PT December 2022 What a year! As 2022 winds to a close, I'm filled with awe and gratitude for the amazing accomplishments of APhA and our members.
December 21 Drugs & Diseases OTCs Today Movin’ right along PT December 2022 According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), constipation is defined as having fewer than three bowel movements a week; stools that are hard, dry, or lumpy; stools that are difficult or painful to pass; or a feeling that not all stool has passed. Mary Warner
December 21 Drugs & Diseases On the Shelf Dancing to the beet PT December 2022 Beetroot juice is well-known in the sports community as a postworkout must and performance enhancer. Mickie Cathers
December 21 Drugs & Diseases New Drug Approval of new ALS drug comes with controversy PT December 2022 After 5 years with no breakthroughs for patients living with amyotrophic lateral sclerosis (ALS), FDA has approved a new oral treatment called Relyvrio from Amylyx Pharmaceuticals. Lauren Howell, PharmD
December 21 Drugs & Diseases Alzheimer Disease Eisai to seek FDA approval for lecanemab, one of dozens of drugs in the Alzheimer pipeline PT December 2022 This fall, biotech Biogen and pharmaceutical company Eisai released topline data on their new antiamyloid monoclonal antibody le-canemab. Sonya Collins
December 21 Drugs & Diseases Biosimilars Ten Humira biosimilars headed to market in 2023 PT December 2022 At least 7 biosimilars for adalimumab (Humira–AbbVie, Inc.) are expected to hit the market in 2023. Sonya Collins
December 21 Drugs & Diseases Diabetes What additional medications might be best for patients taking metformin? PT December 2022 Two recently published articles in the New England Journal of Medicine looked at the comparative efficacy of different medications for the treatment of type 2 diabetes. Johanna Taylor Katroscik, PharmD
December 21 Health Systems Inpatient Insights Inpatient Insights PT December 2022 Although current treatments for patients with Parkinson disease (PD) exist, there are no known treatments that slow disease progression.
December 21 Health Systems Antibiotics Stewardship SHEA releases statement on antibiotic stewardship during public health emergencies PT December 2022 Eighty percent of patients hospitalized during the first 6 months of the COVID-19 pandemic were prescribed antibiotics on admission even though the antimicrobial drugs were rarely indicated at that point. Sonya Collins
December 21 Health Systems Gabapentin Perioperative gabapentin use associated with increased risk of adverse effects in older adults PT December 2022 Investigators studied perioperative gabapentin use to better understand if nonopioid use in multimodal analgesia would be beneficial in reducing opioid use and its adverse effects to improve pain control safely. Clarissa Chan, PharmD
December 21 Health Systems Medication Safety List of medication safety best practices grows in most recent update PT December 2022 The Institute for Safe Medicine Practices (ISMP) updates its Targeted Medication Safety Best Practices for Hospitals list biannually. Olivia C. Welter, PharmD
January 4 Health Systems Pancreatitis Landmark trial suggests aggressive fluid therapy in pancreatitis may cause more harm than good PT December 2022 Randomized controlled trials that investigate the optimal parameters of fluid resuscitation in acute pancreatitis remain scarce. Corey Diamond, PharmD
January 4 CPE CPE Pharmacists increasing access to reproductive health care PT December 2022 People in the United States still struggle to access sexual and reproductive health care, as evidenced by the unintended pregnancy rate of 45%. Ashley H. Meredith, PharmD, MPH, BCACP, BCPS, CDCES, FCCP
December 21 Today's Pharmacist A minute with … Pharmacists in Action PT December 2022 Jennifer Garson, 2023 PharmD candidate at Purdue University College of Pharmacy, Pharmacy Intern, Walgreens, Lafayette, IN